Respiratory News: Breaking Respiratory News, Comments and Articles. - Page: 2

10:16 EDT 5th September 2015 | BioPortfolio

Respiratory News - Page: 2Twitter RSS

Read the latest Respiratory News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Respiratory.

Search or Follow Our Respiratory - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Respiratory - Page: 2 News.
You can also follow our Respiratory - Page: 2 news stories on Twitter: @Respiratory_Bio

Showing "respiratory airways lungs breath" News Articles 26 to 50 of 2,600+

Thursday 3rd September 2015

Teleflex to Present at the 2015 Morgan Stanley Global Healthcare Conference

Benson Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 2015 Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York City, Thursday, September 17, 2015 at 4:05 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be...

WHO statement on the tenth meeting of the IHR Emergency Committee regarding MERS

The tenth meeting of the Emergency Committee (EC) convened by the Director-General under the International Health Regulations (2005) (IHR 2005) regarding the Middle East respiratory syndrome was held by teleconference on 2 September 2015, from 1300 to 1620 Central European Summer Time (UTC +2). During the meeting the WHO Secretariat provided an update to the Committee on epidemiological and scien...

Pyxis® ES Platform Now Live In More Than 600 Sites Nationwide

SAN DIEGO, Sept. 3, 2015 /PRNewswire/ -- CareFusion, a BD company (NYSE: BDX), announces that its enterprise-level Pyxis® ES platform, developed to help hospitals and health systems better manage medications across the care continuum, is now live in more than 600 sites. "Over the past couple of years, there has been noticeable acceleration in the adoption of enterprise-level technology...

Pulmatrix to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2015

LEXINGTON, Mass., Sept. 3, 2015 /PRNewswire/ -- Pulmatrix, Inc., (NASDAQ: PULM) will present at the Rodman & Renshaw 17th Annual Global Investment Conference on Thursday, September 10, 2015 at 11:40 am EDT. As part of the presentation, Robert W. Clarke, Ph.D., Chief Executive Officer for Pulmatrix, will provide an update on the Company's business and its pipeline of inhaled therapeutics. ...

Sandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United States

Novartis International AG / Sandoz launches ZarxioTM (filgrastim-sndz), the first biosimilar in the United States . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Launch follows March 6, 2015 FDA approval Sandoz One SourceTM offers patient support services The digital press release with mul...

ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress

European Regulatory Official Joins Faculty of International Experts Philadelphia (PRWEB) September 03, 2015 ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced the complete faculty of its 8th Annual European PRO and eCOA Congress in Lisbon, Portugal, September 22-24, 2015. The esteemed faculty ...

Wednesday 2nd September 2015

Penn study identifies viral product that promotes immune defense against RSV

(University of Pennsylvania) Research led by University of Pennsylvania's Carolina López found a viral product that promotes a strong immune response against respiratory syncytial virus, a threat to infants and the elderly.

New EWG Interactive Map Shows State-By-State Death Tolls Due to Asbestos-Related Diseases, Baron & Budd Reports

Map Paints a Stark Picture of the Effect Asbestos Has Had in the U.S. An interactive map recently released by the Environmental Working Group (EWG) shows how much of a toll asbestos exposure has taken on the United States, the mesothelioma law firm of Baron & Budd reports. The map shows exactly how many deaths from asbestos-related diseases occurre...

Inhaled Drug Delivery to 2022 : Drugs, Devices, Markets and Forecasts

LONDON, Sept. 2, 2015 /PRNewswire/ -- The upper airway diseases Asthma and COPD remain significant health challenges for both patients and clinicians. Inhalers that combine two drugs indicated for treating upper airway diseases in one inhaler are gaining interest due to the complementary therapeutic effects of certain classes of drugs when taken together. Systemic delivery continues to represent a...

ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights

September Installments Address Data Analytics vs. Reporting, Future of Cardiac Safety Testing and eCOA Trial Design in GI Indications PHILADELPHIA (PRWEB) September 02, 2015 ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced the September 2015 installments to its Endpoints to Insights Educatio...

UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder

Frequent nosebleeds are often the first sign of HHT, which can cause sudden, catastrophic bleeding. Pittsburgh, PA (PRWEB) September 02, 2015 A UPMC and University of Pittsburgh Schools of the Health Sciences clinical and academic partnership has earned international recognition as a premier center for treatment of and research into hereditary hemorrhagic telangiectasia (HHT), a rare genetic diso...

Team developing new drug against leading causes of death—sepsis and ARDS

Scientists at Queen's University Belfast are developing a potential revolutionary new treatment for Sepsis and Acute Respiratory Distress Syndrome (ARDS), which are among the leading causes of death in hospitalised patients in the UK.

Revolade® Receives EU Approval as First-in-Class Therapy for Patients with Severe Aplastic Anemia

Revolade is marketed as Promacta® in the USA Revolade is the first approved therapy in the EU for patients with severe aplastic anemia (SAA) who have not responded to other treatments Two out of every one million people in Europe are diagnosed with aplastic anemia per year, and patients with severe cases have limited ...

Brightree and ResMed Further Enhance Integrated Sleep Therapy Capabilities

Complete, Automated End-to-End Solution Benefits HME Providers from Initial Patient Setup, Through Compliance, Resupply and Electronic Document Storage Brightree®, the leading provider of cloud-based clinical, billing and business management software solutions for the post-acute care industry, today announced enhanced integration capabilities f...

CA Air in Critical Condition, Climate Action Needed, Lung Association Says

SACRAMENTO, Calif., Sept. 2, 2015 /PRNewswire/ -- California's air is in critical condition and because of that, the American Lung Association in California today launched an online campaign featuring an urgent call to address climate pollution. The campaign features Dr. Felix Aguilar, a family practice physician who regularly administers breathing treatments to his patients in Los Angeles. ...

Generex Announces Formalization of Buccal Cannabis Co-Development Plan

Contract signed with CannScience Innovations Inc. WORCESTER, Mass. and TORONTO, Sept. 2, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that its previously announced intention to implement a buccal cannabis co-development arrangement with CannScience Innovations Inc. (www.cannsci.com) has been formalized. Generex and CannScience have...

U.S. FDA Approves Update of SIMPONI ARIA® (golimumab for infusion) Label to Include Improvement in Both Physical and Emotional Measures of Health When Treating Moderately to Severely Active Rheumatoid Arthritis

HORSHAM, Pa., Sept. 2, 2015 /PRNewswire/ -- Janssen Biotech, Inc. announced today the approval of a U.S. Food and Drug Administration (FDA) Supplemental Biologics License Application (sBLA) for SIMPONI ARIA® (golimumab for infusion) for the treatment of moderately to severely active rheumatoid arthritis (RA) to include measures of physical and mental health reported by patients through t...

Pulmatrix Issued New Composition of Matter Patent Covering iSPERSE™ Technology

LEXINGTON, Mass., Sept. 2, 2015 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM) has been granted U.S. patent 9,119,778, for the Company's underlying iSPERSE™ inhaled dry powder technology. The patent broadly covers small, dense and dispersible dry powders that are comprised of proprietary combinations of divalent cation salts and excipients. These patented dry powders have the potential to en...

Hastings & Hastings Speaks Out About Stress and Road Rage

PHOENIX, Sept. 2, 2015 /PRNewswire/ -- Studies show that up to 1,500 people are injured or killed in road rage incidents each year. Hastings & Hastings would like to see this number reduced to zero. Logo - http://photos.prnewswire.com/prnh/20150901/263043LOGO Hastings & Hastings acknowledges the stress of driving, especially during the heat of summer as temperatures rise and tempers sta...

EarlySense Brings Hospital Care Expertise to the Home

RAMAT GAN, Israel, September 2, 2015 /PRNewswire/ -- EarlySense, the market leader in contact-free, health and wellness sensing and analytics, announced today the release of myEarlySense, its first OEM solution for the digital health consumer market. The new sleep and wellness monitoring solution will be showcased at the upcoming IFA event, taking place in Berlin on September 4-9. myEarlySense t...

Tuesday 1st September 2015

Knee and hip replacements 'linked with poorer heart health'

A new study from the US has demonstrated a link between hip and knee replacements and a higher risk of poor heart health outcomes.Led by the Boston University School of Medicine, the study aimed to examine whether joint replacement surgery affected the risk of serious cardiovascular events among osteoarthritis patients.A total of 13,849 patients who underwent total knee replacement surgery were ma...

Dehaier Medical Systems Showcases Its Wearable Sleep Respiratory Solution at Two Premier Sleep Conferences

BEIJING, Sept. 02, 2015 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), which develops, markets and sells medical devices and wearable sleep respiratory products in China, today announced that it has showcased its wearable sleep respiratory product and solution at two premier sleep respiratory conferences, including: 1) the 4th National Sleep Respi...

Respiratory Care for SCI Patients

Ensuring clinical competency in the care of medically complex patients.

From little grants big labs grow

The idea “When I first started at Monash, in about October 2006, one of the first things that I did was sit down and go through the websites of all the different philanthropic funding organisations that fund biomedical research,” Associate Professor McIntosh said. “I’d written a research proposal asking for funding for equipment to help me establish a lab that would allow me to look at dr...

Theravance to Present at Two Upcoming Investor Conferences in September

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/02/15 -- Theravance, Inc. (NASDAQ: THRX) announced today that Michael W. Aguiar, Theravance's President and Chief Executive Officer, will present at two upcoming conferences in September 2015: Baird 2015 Healthcare Conference Wednesday, September 9 at 9:05 a.m. EDT, New York Morgan Stanley Global Healthcare Conference Thursday, September 17 at 3:3...



Advertisement
 
Advertisement
 

News Quicklinks